Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 25 versus OSMITROL 5 IN WATER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 25 versus OSMITROL 5 IN WATER.
MANNITOL 25% vs OSMITROL 5% IN WATER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases plasma osmolarity, drawing water from intracellular and interstitial spaces into the intravascular compartment. In the kidney, it is filtered but not reabsorbed, increasing tubular fluid osmolarity and promoting water excretion. It also reduces intracranial and intraocular pressure by creating an osmotic gradient.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular and interstitial spaces into the extracellular compartment, thereby reducing cerebral edema and intraocular pressure; also promotes diuresis by increasing renal tubular fluid osmolality.
1-2 g/kg (4-8 mL/kg) intravenously as a 25% solution over 30-60 minutes; may repeat every 6-8 hours as needed.
50-100 g intravenously as a 5% solution over 30-60 minutes; may repeat every 6-8 hours as needed. Maximum dose: 200 g in 24 hours.
None Documented
None Documented
Terminal elimination half-life: 0.25–1.7 hours; prolonged in renal impairment.
Approximately 0.25-1.5 hours (15-90 minutes); prolonged in renal impairment or with mannitol accumulation (e.g., in anuria).
Renal: >90% unchanged by glomerular filtration; biliary/fecal: <5%.
Primarily renal (90-100% unchanged in urine); negligible biliary or fecal elimination.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic